VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-00257
Package ID: USCOURTS-cofc-1_20-vv-00257
Petitioner: M.L.P.
Filed: 2020-03-06
Decided: 2021-10-29
Vaccine: Gardasil
Vaccination date: 2017-03-08
Condition: Postural tachycardia syndrome (“POTS”), and small fiber neuropathy
Outcome: dismissed
Award amount USD: 

AI-assisted case summary:
On March 6, 2020, Amy J. Pennell, as guardian of minor M.L.P., filed a petition for compensation under the National Vaccine Injury Compensation Program. The petition alleged that M.L.P. suffered from Postural Tachycardia Syndrome (POTS) and small fiber neuropathy as a result of receiving the Gardasil vaccine on March 8, 2017. Supporting medical records were filed with the initial petition. On October 6, 2021, the petitioner filed a motion to dismiss her own petition, stating her intention to opt out of the Vaccine Program to pursue a third-party action directly against Merck, the vaccine manufacturer. The petitioner clarified that this decision was a strategic choice and did not reflect a lack of belief in the merits of her claim or M.L.P.'s injuries. She understood that a dismissal would result in a judgment against her, ending her rights within the Vaccine Program, and that she intended to reject this judgment to file a civil action. The Special Master noted that the petitioner had not presented evidence of a Table Injury and that insufficient evidence had been presented to justify an award at that time. Given the petitioner's request to dismiss the case to pursue other legal avenues, the Special Master granted the motion. The case was dismissed for insufficient proof, and judgment was entered accordingly. The public decision does not describe the onset of symptoms, specific medical tests performed, treatments received, or the mechanism of injury. Petitioner's counsel was Andrew D. Downing of Van Cott & Talamante, PLLC. Respondent's counsel was Camille M. Collett of the U.S. Department of Justice. Special Master Thomas L. Gowen issued the decision.

Theory of causation field:
Petitioner alleged that M.L.P. suffered from Postural Tachycardia Syndrome (POTS) and small fiber neuropathy as a result of receiving the Gardasil vaccine on March 8, 2017. The petition was dismissed upon petitioner's motion to opt out of the Vaccine Program to pursue a third-party action against the manufacturer. The Special Master noted that no evidence of a Table Injury was presented and insufficient evidence was provided to justify an award. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. The case was dismissed for insufficient proof on October 29, 2021, by Special Master Thomas L. Gowen. Petitioner's counsel was Andrew D. Downing, and respondent's counsel was Camille M. Collett.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_20-vv-00257-0
Date issued/filed: 2021-10-29
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 10/7/2021) regarding 20 DECISION of Special Master. Signed by Special Master Thomas L. Gowen. (hs) Service on parties made.
--------------------------------------------------------------------------------
Case 1:20-vv-00257-UNJ Document 24 Filed 10/29/21 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: October 7, 2021
* * * * * * * * * * * * *
AMY J. PENNELL, guardian of *
minor, M.L.P., * UNPUBLISHED
*
Petitioner, * No. 20-257V
*
v. * Special Master Gowen
*
SECRETARY OF HEALTH * Motion for Dismissal Decision;
AND HUMAN SERVICES, * Human Papillomavirus (“HPV”)
* Gardasil.
Respondent. *
* * * * * * * * * * * * *
Andrew D. Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for petitioner.
Camille M. Collett, U.S. Department of Justice, Washington, D.C., for respondent.
DISMISSAL DECISION1
On March 6, 2020, Amy J. Pennell, as guardian of minor, M.L.P., filed a petition for
compensation in the National Vaccine Injury Compensation Program.2 Petition (ECF No. 1).
Petitioner alleged that M.L.P. suffered from a severe adverse reaction, including Postural
tachycardia syndrome (“POTS”), and small fiber neuropathy, as a result of receiving the Gardasil
vaccine on March 8, 2017. Petition at Preamble. Petitioner filed supporting medical records
with the petition.
On October 6, 2021, petitioner filed a motion for a decision dismissing the petition.
Petitioner’s Motion (“Pet. Mot.”) (ECF No. 19). Petitioner stated that she has made the choice to
“opt out of the Vaccine Program,” and that “[S]he wishes to pursue a third-party action in district
court against Merck directly.” Pet. Mot. at ¶ 3. She continued, “[t]his choice should not be
1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a
reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of
Federal Claims. The Court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the opinion
is posted on the Court’s website, each party has 14 days to file a motion requesting redaction “of any information
furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or
confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). An objecting party must provide the Court with a proposed
redacted version of the opinion. Id. If neither party files a motion for redaction within 14 days, the opinion will
be posted on the Court’s website without any changes. Id.
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended 42 U.S.C. §§ 300aa-10 to 34 (2012)
(hereinafter “Vaccine Act” or “the Act”). Hereinafter, individual section references will be to 42 U.S.C. § 300aa of
the Act.

Case 1:20-vv-00257-UNJ Document 24 Filed 10/29/21 Page 2 of 2
viewed in any way that Petitioner does not believe in the merits of her claim or that [M.L.P.’s]
injuries are not a result of Gardasil…..[she] needs a judgment from the Vaccine Program so that
she may reject said judgment and submit her election to opt out.” Id. Petitioner stated that, “to
proceed further would be unreasonable and would waste the resources of the Court, the
respondent, and the Vaccine program. Id. at ¶ 3.
Petitioner understands that an adverse decision in the Vaccine Program dismissing her
petition will result in a judgment against her and that such judgment will end all of her rights in
the Vaccine Program. Id. at ¶ 4. Therefore, petitioner intends to elect to reject the Vaccine
Program judgment against her and elect to file a civil action at the appropriate time. Id.
To received compensation under the Vaccine Program, petitioners must prove either (1)
that she suffered a “Table Injury,” i.e. an injury falling within the Vaccine Injury Table-
corresponding to the vaccination, or (2) that she suffered an injury that was actually caused by a
vaccine. See §§ 13(a)(1)(A), 11(c)(1). An examination of the record did not uncover any
evidence that M.L.P. suffered a Table Injury. Further, the information in the record indicates
that insufficient evidence has been presented to justify an award at this time. Petitioner also
notes that to proceed further would be unreasonable and would waste the resources of the Court,
the respondent and the Vaccine program. As such, the petition is hereby, DIMISSED.
Thus, petitioner’s motion is GRANTED. This matter is DISMISSED for insufficient
proof. The Clerk of the Court shall enter judgment accordingly.3
IT IS SO ORDERED.
s/Thomas L. Gowen
Thomas L. Gowen
Special Master
3 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule
11(a).
2